do glp 1 drugs cause fatigue GLP-1 Receptor Agonist Mechanism: Causes and Management Improvement in symptoms with GLP-1

Liraglutide, a once-daily human GLP-1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding rosiglitazone or placebo in subjects with Type 2 diabetes (LEAD-1 SU)

doi: 10.1093/ajcn/77.3.605

Acknowledgements The authors thank Dr

Notably, compared to non-obese animals lacking human DPP4, diabetic mice challenged with MERS-CoV experienced a more severe course of the illness and a more extended period of recovery

While these symptoms are far more commonly caused by benign conditions, they require evaluation to exclude thyroid pathology or other serious causes